Cephalosporin Market: Size, Share, Growth, Analysis, Key Players, Revenue, Growth | Valuates Reports

Cephalosporin Market Size
The global Cephalosporin market was valued at US$ 1380.7 million in 2023 and is anticipated to reach US$ 1346.9 million by 2030, witnessing a CAGR of -0.3% during the forecast period 2024-2030.

View sample report
https://reports.valuates.com/request/sample/QYRE-Auto-16X255/Global_Cephalosporin_Market_Insights_Forecast_to_2025

Cephalosporin Market
Cephalosporin is an antibiotic medication commonly prescribed to treat several different types of infections.
Cephalosporin originally derived from the fungus Acremonium, which was previously known as "Cephalosporium".
Market competition is intense. Qilu Antibiotics, Nectar Lifesciences, Shandong Ruiying Pioneer Pharmaceutical, NCPC and ACS Dobfar are the top 5 of Cephalosporin, with about 50% market shares.China is the largest supplier of Cephalosporin, with a production market share nearly 70%. India is the second largest supplier of Cephalosporin, enjoying production market share nearly 21%.China is the largest consumption place, with a consumption market share nearly 40%. Following China, India is the second largest consumption place with the consumption market share of 39%. The classification of Cephalosporin includes First Generation, Second Generation, Third Generation, Fourth Generation and the proportion of Third Generation is about 61%.Cephalosporin is widely used in d Oral drugs and Injection drugs. The most proportion of Cephalosporin is Injection drugs, and the consumption proportion is about 80%.
This report aims to provide a comprehensive presentation of the global market for Cephalosporin, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cephalosporin.

Get regional report
https://reports.valuates.com/request/regional/QYRE-Auto-16X255/Global_Cephalosporin_Market_Insights_Forecast_to_2025

Segment by Type
• First Generation Cephalosporin
• Second Generation Cephalosporin
• Third Generation Cephalosporin
• Fourth Generation Cephalosporin

Segment by Application
• Oral
• Injection

By Company
Union Chempharma, NCPC, Qilu Antibiotics, Lupin Pharmaceuticals, Hospira, Dhanuka Laboratories, Fukang, Dongying Pharmaceutical, Alkem, SALUBRIS, LIVZON, Hetero Drugs, CSPC, TEVA, Orchid Pharma, Taj Pharmaceuticals, Covalent Laboratories, United Laboratories, Aurobindo, Wockhardt, LKPC, HPGC, Huafangpharm, Liaoning Medya Pharmaceutical., Sichuan Kelun Pharmaceutical, Suzhou Dawnrays Pharmaceutical, Fuan Pharmaceutical, Harbin Pharmaceutical Group, Shandong Ruiying Pioneer Pharmaceutical, Guangdong Liguo Pharmaceutical, Nectar Lifesciences, ACS Dobfar, Novartis

View full report
https://reports.valuates.com/market-reports/QYRE-Auto-16X255/global-cephalosporin

Valuates,
4th Floor,
Balaraj's Arcade,
Whitefield Main road,
Bangalore 560066,

Valuates offers an extensive collection of market research reports that helps companies to take intelligent strategical decisions based on current and forecasted Market trends.

This release was published on openPR.